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Encouraging awareness of fetal movements is harmful
The concept that perception by pregnant women of 
reduced or altered movements of their fetuses can be 
used to predict stillbirth, thereby enabling early birth 
to save the baby, seems plausible.1 However, although 
mothers of stillborn babies, with hindsight, remember 
altered movements preceding the diagnosis of the death 
more often than controls,2,3 to our knowledge, no one 
has ever shown this prospectively. With few exceptions,4 
the accuracy of tests of fetal health done in response to 
altered movements has been poorly evaluated, and the 
only treatment—delivery—can harm as well as benefit.5 
A 2015 Cochrane review6 on routine perinatal fetal 
movement counting was dominated by a cluster trial by 
Adrian Grant and colleagues,7 who investigated routine 
use of movement counting among 68 000 women and 
found that this method “did not translate into reduced 
perinatal mortality”.
Nevertheless, encouraging maternal awareness of 
changes in fetal movements remains popular; this 
suggestion was advocated by the Saving Babies’ Lives 
publication by NHS England,8 largely on the basis of 
a study9 that compared awareness campaigns with 
historical controls. This is weak evidence because other 
changes, such as increasing the frequency of term 
inductions and reduced smoking among pregnant 
mothers, could also have prevented stillbirth.
However, in The Lancet, Jane Norman and colleagues10 
have more thoroughly evaluated this policy. This 
stepped-wedge, cluster-randomised trial assessed 
a programme that encouraged enhanced maternal 
awareness and rapid reporting of changes in fetal 
movement, which was combined with training of staff 
to respond with a defined programme of further testing 
and, if necessary, to induce delivery. The advice to 
pregnant women was that they should monitor changes 
in movements from 24 weeks, and that they should 
refer themselves immediately if they detected altered 
movement after 28 weeks. Control centres gave usual 
care, and the primary outcome was stillbirth. More than 
400 000 pregnancies at 33 hospitals were included, so 
the study was powered to exclude even modest effects. 
The intervention was associated with an induction 
rate of 41%, compared with 36% in the control group 
(adjusted odds ratio [AOR] 1·05, 95% CI 1·02–1·08); 
if the correct women had been induced and no harm 
caused, this intervention should have had a substantial 
effect. The Saving Babies’ Lives stated that the AFFIRM 
trial “will give us the best evidence yet”.8 
Unfortunately, stillbirths were not significantly re-
duced by this intervention (AOR 0·90, 95% CI 0·75–1·07) 
and there was no effect on perinatal mortality 
(0·98, 0·83–1·17). However, appendix data showed 
a higher number of postneonatal deaths in those 
receiving the intervention than in the control group. 
The intervention also had associated costs, including 
a significantly higher use of caesarean sections 
of 28%, compared with 25% in the control group 
(1·09, 1·06–1·12), and more prolonged admissions to the 
neonatal unit (1·12, 1·06–1·18).
The trial was prospectively registered and well 
conducted, and the results are plausible. Altered 
fetal movements are so commonly reported that the 
specificity of these reports must be low; some hospitals 
have more women attending for this reason than 
for births over the same period. Repeated episodes 
of reduced fetal movement can be so stressful to the 
mother that some doctors are persuaded to induce, 
even if further tests are normal. There are also anecdotes 
of women feigning reduced fetal movements to 
attain an ultrasound scan or induction of labour. The 
prevalence of women falsifying reduced fetal movement 
is important because, although induction of birth at 
full term is unlikely to seriously harm the mother or 
the baby,11 preterm induction has risks. With hindsight, 
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In 2015, 2·6 million stillbirths were estimated globally, 
more than 7100 deaths a day, with most occurring in 
developing countries.1 These figures are substantial, 
yet they are an underestimation of the full extent of 
this loss because stillbirths at less than 28 weeks of 
pregnancy are not included in these numbers.2 If the 
22-week threshold was applied, the numbers have been 
estimated to be 40% higher.2
Survival of very preterm babies has increased con-
siderably over the past decades in high-income 
countries (HICs),3 and the threshold of viability at 
birth has been reviewed over time.2,4 Although WHO 
recommends the 28-week threshold for international 
comparison of stillbirths, WHO and the International 
Statistical Classification of Diseases and Related Health 
Problems 10th Revision both recommend 22 weeks 
of gestation as a threshold for ascertainment of fetal 
death, with registration and collation of data from 
22 weeks. However, international differences in 
legislation, especially in HICs with differing policies on 
viability at extremes of gestational age and other factors 
including fatalism and a lack of accountability, lead to 
under-reporting of stillbirths.2,3
In The Lancet, Lucy K Smith and colleagues4 quantified 
the burden of stillbirths before 28 weeks in Europe. In 
this population-based study, they used national cohort 
data from 19 European countries, collected between 
2004 and 2015, with pregnancy outcomes from 
22 weeks, and calculated pooled stillbirth rates and 
changes in rates. In 2015, more than 9000 babies were 
stillborn from just over 2·5 million births in Europe, and 
of these 6294 (32%) were stillbirths between 22 weeks 
Stillbirths count, but it is now time to count them all
the recommendation to encourage mothers to report 
changes from as early as 28 weeks might have been 
misguided. Although overall deaths were not stratified 
by duration of gestation, it is plausible that limiting 
awareness campaigns to beyond 37 weeks would be 
safer.
Two other cluster trials are ongoing: My Baby’s 
Move ments among 250 000 women in Australia 
(Aus tralian New Zealand Clinical Trials Registry, 
ACTRN12614000291684) and Mindfetal among 39 000 
women in Sweden (ClinicalTrials.gov, NCT02865759), so 
the AFFIRM authors suggest delaying policy changes until 
results of these trials are reported.
Nevertheless, given that the AFFIRM trial assesses 
a large population and is in agreement with the only 
previous large trial,7 opinion and practice leaders need to 
consider how current guidelines might be revised. Failure 
of health-care providers to respond to reported changes 
to fetal movement is probably impossible. However, 
discouraging campaigns that promote awareness 
preterm, improving induction guidelines, and not 
inducing delivery in response to perception of altered 
movement alone would seem to be sensible first steps.
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